semaglutide joe rogan Sanjay Gupta | There hasn't been a new medication approved to treat alcohol use disorder in the last 20 years. That may soon change with GLP-1 drugs like Peptides: TB-500, BPC-157 haven't been

No currently approved oral GLP-1 offers the same flexibility

Reassess after any acute illness, dehydration, or suspected pancreatitis

BPC-157 works by promoting angiogenesis, the formation of new blood vessels, and activating growth factor receptors that accelerate tissue repair

Given that CAD increases atrial tissue excitability by promoting reentry, exacerbating ischemia, and inducing electrical heterogeneitythus accelerating AF progressiontheir protective action against CAD may indirectly lower AF risk (158, 159)

Epidemiological studies and early clinical data suggest that GLP-1 receptor agonists may reduce the risk of neurodegenerative diseases including Alzheimer disease, Parkinson disease, and other forms of dementia

By integrating this knowledge into our practice, we can move beyond mere symptom management and work towards truly restoring health and enhancing the quality of life for these patients